MillicomTigo-azul-transparente.png
Millicom (Tigo) notice of first quarter 2023 results and video conference
18 avr. 2023 14h28 HE | Millicom International Cellular S.A.
Millicom (Tigo) notice of first quarter 2023 results and video conference Luxembourg, April 18, 2023 – Millicom expects to announce its first quarter 2023 results on April 27, 2023 via a press...
Summit Master_rgb_png.png
Notice of Results
10 oct. 2019 09h30 HE | Summit Therapeutics plc
Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2019 on 11 October 2019 Oxford, UK, and...
Logo TIGO MIC Blue.png
Notice of third quarter 2019 results and conference call
20 sept. 2019 13h00 HE | Millicom International Cellular S.A.
Notice of third-quarter 2019 results and conference call  Luxembourg, 20 September 2019 – Millicom will announce its third-quarter results for the period ending 30 September 2019, on 23 October...
Summit Master_rgb_png.png
Notice of First Quarter Results
05 juin 2019 09h00 HE | Summit Therapeutics plc
Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Therapeutics Provides Notice of Financial Results for the First Quarter Ended 30 April 2019 Oxford, UK, and Cambridge, MA, US, 5 June 2019...
Summit Master_rgb_png.png
Summit Therapeutics to Report Financial Results for the Third Quarter and Nine Months Ended 31 October 2017 on 6 December 2017
04 déc. 2017 07h00 HE | Summit Therapeutics plc
OXFORD, United Kingdom, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...
Summit Master_rgb_png.png
Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2017
27 mars 2017 07h00 HE | Summit Therapeutics PLC
OXFORD, United Kingdom, March 27, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...